Fresh Recalls

FDAClass II · Drug · Recall D-0628-2026 · Recalled July 1, 2026

Perampanel CIII Tablets recall — SUN PHARMACEUTICAL INDUSTRIES INC

Agency report date: July 1, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Perampanel CIII Tablets
Company / brand
SUN PHARMACEUTICAL INDUSTRIES
Lot / serial / date codes
Lot AE01763, Expires 9/30/2027.
Distribution
Nationwide in the USA
Agency product description and boundaries

Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Perampanel CIII Tablets

3. Open the official notice or contact

Official recall ID
D-0628-2026
Brand
SUN PHARMACEUTICAL INDUSTRIES
Classification
Class II
Units affected
3,456 30-count bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Princeton, NJ, United States
Firm address
2 Independence Way, N/A, 08540-6620

Identifying details (verbatim from the notice)

Product codes / lots
Lot AE01763, Expires 9/30/2027.
Distribution
Nationwide in the USA
Firm notified the public via
Letter
FDA event ID
99256
Recall initiated
June 17, 2026
FDA classified
June 26, 2026
FDA report date
July 1, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page